|
|
|
|
|
by ninalanyon
435 days ago
|
|
> This inability to bring a product to market is in fact an artifact of the for-profit healthcare system. If that were the only, or principal, problem then surely we would notice that single payer systems do better by demanding production of other therapies. |
|
Large pharma is going to develop in the US, where tax dollars fund a significant portion of research, and they get exclusive ownership of the resulting product.
Single payer systems do still display advantages for the drug's users.
Surely you've heard of people in the US buying prescription meds from Canada?